Afuresertib
CAS No. 1047644-62-1
Afuresertib ( GSK 2110183;GSK2110183;GSK-2110183 )
Catalog No. M10234 CAS No. 1047644-62-1
A potent, selective, ATP-competitive pan-AKT inhibitor with biochemical IC50 of 0.08/2/2.6 nM for AKT1/2/3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 41 | In Stock |
|
5MG | 65 | In Stock |
|
10MG | 88 | In Stock |
|
25MG | 160 | In Stock |
|
50MG | 259 | In Stock |
|
100MG | 453 | In Stock |
|
500MG | 981 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAfuresertib
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, ATP-competitive pan-AKT inhibitor with biochemical IC50 of 0.08/2/2.6 nM for AKT1/2/3.
-
DescriptionA potent, selective, ATP-competitive pan-AKT inhibitor with biochemical IC50 of 0.08/2/2.6 nM for AKT1/2/3; also inhibits PKA (IC50=1.3 nM) and AKT1 E17K mutant (IC50=0.2 nM), selective over PKC, PKG isoforms and p70S6K; orally bioactive.Gastric Cancer Phase 1 Discontinued
-
SynonymsGSK 2110183;GSK2110183;GSK-2110183
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptorAkt1;Akt2;Akt3
-
Research AreaCancer
-
IndicationGastric Cancer
Chemical Information
-
CAS Number1047644-62-1
-
Formula Weight427.32
-
Molecular FormulaC18H17Cl2FN4OS
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 40 mg/mL
-
SMILESCN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)N[C@@H](CC3=CC(=CC=C3)F)CN)Cl
-
Chemical Name2-Thiophenecarboxamide, N-[(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dumble M, et al. PLoS One. 2014 Jun 30;9(6):e100880.
2. Spencer A, et al. Blood. 2014 Oct 2;124(14):2190-5.
3. Arceci RJ, et al. Pediatr Blood Cancer. 2017 May;64(5).
2. Spencer A, et al. Blood. 2014 Oct 2;124(14):2190-5.
3. Arceci RJ, et al. Pediatr Blood Cancer. 2017 May;64(5).
molnova catalog
related products
-
GSK-690693
A potent, ATP competitive, pan-AKT inhibitor with IC50 of 2, 13, and 9 nM against AKT1, 2, and 3, respectively.
-
Sennidin A
Sennidin A has two hydroxyanthraquinone-like moieties exerts inhibition on NS3 helicase with IC50 values of 0.8 μM.
-
(E)-Akt inhibitor-IV
(E)-Akt inhibitor-IV? ((E)-AKTIV) is an inhibitor of PI3K-Akt.